Surpass Elite with GUARDian Flow Diverter (GUARD)

· Stryker Neurovascular

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Surpass Elite with GUARDian Flow Diverter (GUARD), covering 2026-04-08 to 2026-04-08. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Endovascular Treatment of Intracranial Aneurysms With Surpass Elite With GUARDian Flow Diverter (GUARD) [NA]

See pricing